Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

tDCS for Treatment Resistant Obsessive Compulsive Disorder

NCT: NCT03304600 · COMPLETED

NCT IDNCT03304600
StatusCOMPLETED
Start Date2017-11-03
Completion2022-02-24
SponsorCentre Hospitalier Henri Laborit (OTHER)
First posted
Last updated

Brief Summary

It's a multicentric, randomized, controlled study concerning 100 patients with treatment-resistant obsessive compulsive disorders (OCD). The aim of this study is to evaluate the effect of transcranial direct current stimulation (tDCS) on OCD patients.

Frequently Asked Questions

What is tDCS for Treatment Resistant Obsessive Compulsive Disorder?

tDCS for Treatment Resistant Obsessive Compulsive Disorder is a clinical trial registered under NCT03304600. Current status: COMPLETED.

What is the status of NCT03304600?

The current status of NCT03304600 (tDCS for Treatment Resistant Obsessive Compulsive Disorder) is: COMPLETED.

When did tDCS for Treatment Resistant Obsessive Compulsive Disorder start?

tDCS for Treatment Resistant Obsessive Compulsive Disorder started on 2017-11-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.